We had the pleasure of hosting Dr. Malú Tansey, Professor of Neuroscience and Director of the Center for Translational Research in Neurodegenerative Disease at the University of Florida, to discuss a new, alternative model for Alzheimer's disease. Tune in to learn how genetic and environmental risk factors combine to increase disease risk, and how Professor Tansey's approach could reshape how we treat Alzheimer’s 🧠 Watch it here: https://lnkd.in/exGWZKNa
Abcam
Biotechnology Research
Cambridge, Cambridgeshire 58,606 followers
About us
At Abcam, we believe the scientific community goes further, faster when we go there together. And to keep on making ground-breaking discoveries, we need to work together in new ways. That’s why we’re constantly innovating to help scientists drive their research forward by providing products and solutions that play an essential role in fundamental research, drug discovery, diagnostic and therapeutic applications. We started with a simple mission: to provide the best biological reagents to life scientists worldwide. Today, we help 750,000 researchers in over 130 countries deliver faster breakthroughs in areas like cancer, neurological disorders, infectious diseases, and metabolic disorders. Abcam is proud to be part of Danaher. Danaher is a global science and technology leader. Together we combine our capabilities to accelerate the real-life impact of tomorrow’s science and technology to improve human health.
- Website
-
https://www.abcam.com/
External link for Abcam
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Cambridge, Cambridgeshire
- Type
- Public Company
- Specialties
- antibodies, custom services, proteins, gene-edited cell lines, knockout cell lines, rabbit antibodies, immunoassays, biological reagents, monoclonal antibodies, research, drug discovery , diagnostics, RabMAb, and Life Sciences
Locations
Employees at Abcam
Updates
-
We’re thrilled to share the program for #CancerAndMetabolism! 🎉 Join us on February 9-10 for an extraordinary two-day conference featuring major influencers in the field, including: 🌟 Alec Kimmelman – NYU Langone Health 🌟 Eileen White – Rutgers Cancer Institute 🌟 Matthew Vander Heiden MD, PhD – MIT Koch Institute for Integrative Cancer Research Don't miss this opportunity to gain insights from these key opinion leaders and explore groundbreaking research in #cancer and #metabolism. 👉 Visit our website to explore the full program and register today: https://lnkd.in/eYdnpnJA
-
-
You have your hypothesis. Your experiments are planned. Now you need results, and our antibodies will give you the precision you need. We use recombinant technology and extensive validation techniques to ensure consistent, reliable results from the first step to the last. Follow the link to learn more: https://lnkd.in/emKi-Un
-
-
Join our online immunology community for the latest session of #InflammaZoom, our free webinar series dedicated to #innateimmunity and #inflammasome biology! 📅 November 21 ⏰ 3.30pm-4.30pm GMT 🎤 Featuring talks from the London School of Hygiene and Tropical Medicine, U. of London and the University of Iowa. Register for free to access the live session, plus revisit on-demand talks from earlier in the year: https://lnkd.in/gXksPDUT
-
-
Our very own Hannah Cable, Vice President of New Product Development, was interviewed by Nature to discuss how we’re fueling the recombinant revolution with our extensive portfolio of over 32,000 highly specific recombinant antibodies. Check out the full article here: https://lnkd.in/eeed7a5P As long-time advocates of recombinant technology, we’re thrilled to see more researchers making the switch. And with benefits like these, it’s a wonder why it hasn’t happened sooner: ✅ Improved reproducibility ✅ Time saved in the lab ✅ Unrivaled specificity ✅ Batch-to-batch consistency ✅ Ease of scalability For more information on our range of recombinant antibodies, click here: https://lnkd.in/eYsq_YuD
-
In many cancers, including glioblastoma, the MAPK signaling pathway is often deregulated or mutated. Our poster explores this pathway's complex mechanisms and highlights its significance in cancer progression. Download now to understand MAPK's role in glioblastoma and find the best products to support your research. 📥 Discover the MAPK Pathway: https://bit.ly/3UFuZnl
-
-
We were very fortunate to have Irene Posse Alonso speak at our Advancements in Mucosal Immunology conference this week at Harvard Medical School! As well as hearing insightful talks from Shruti Naik (Icahn School of Medicine at Mt Sinai), Megan Orzalli (UMass Chan Medical School), Scott Snapper (Harvard Medical School/Boston Children's Hospital), Gretchen Diehl (Memorial Sloan Kettering Cancer Center), Jose Ordovas-Montanes (Harvard Medical School/Boston Children), Jie Sun (University of Virginia Medical School), Smita G. (Harvard T.H. Chan School of Public Health) and our conference chair Ivan Zanoni (Harvard Medical School/Boston Children's Hospital), to name a few. Thank you to everyone involved! #MucosalImmunology2024
This week I presented at the Abcam conference in Advances in Mucosal Immunity at Harvard Medical School! It was an exciting opportunity to share my research and learn about recent developments in the field. I specially enjoyed talks from Shruti Naik or Megan Orzalli among others. Truly mesmerizing couple of days! Thank you Abcam for organizing the event and for giving me the chance to learn more about the crosstalk between the immune cells and these barrier tissues!
-
-
When you’re looking for low abundance targets, why use anything but the highest quality immunoassays optimized for sensitivity? Even at small sample volumes, our leading immunoassay technology can identify your module of interest and deliver results. Learn how: https://lnkd.in/eVBUVXU
-
The #1 cited antibody – now for 20% less. Labs rely on antibodies like these. That’s why we’ve reduced its price by 20% to keep your research moving forward. Find out more here: https://bit.ly/3NThPyY
-
Biophysical quality control detects any impurities and aggregates and provides us with a unique profile or ‘fingerprint’ of each product that isn’t open to interpretation. Our innovative technique was recognized by CiteAb 2024, winning the Highly Commended Digital Science Tool of the Year award. Read more here: https://lnkd.in/em5N22TV
-